What is the current size of the optical genome mapping market?

The optical genome mapping market was valued at USD 165.75 million in 2025 and is forecast to reach USD 474.59 million by 2030, growing at a 23.42% CAGR. Read More

Which product segment is expanding fastest?

Consumables are the fastest-growing product segment, advancing at a 25.93% CAGR as laboratories run more tests on the expanding installed base of instruments. Read More

Why are rare-disease diagnostics important for optical genome mapping?

Optical genome mapping identifies pathogenic structural variants that short-read sequencing misses, delivering definitive diagnoses in 15% of previously unresolved rare-disease cases. Read More

Which region shows the highest growth potential?

Asia Pacific leads in growth with a projected 30.01% CAGR through 2030, driven by China’s precision-medicine program and Japan’s TOP-GEAR cancer-genomics initiative. Read More

How does optical genome mapping improve oncology testing?

The technology achieves 98.2% concordance with standard cytogenetic methods while revealing additional actionable variants in 58% of hematological malignancy samples, guiding more precise therapy selection. Read More

What is the main barrier to wider adoption?

High upfront instrument costs remain the primary obstacle, although leasing models, reimbursement progress, and workflow-consolidation savings are steadily lowering this barrier. Read More

Optical Genome Mapping Companies

This report lists the top Optical Genome Mapping companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Optical Genome Mapping industry.